Stay updated on NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.

Latest updates to the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the prior notices including the funding-related notice (v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide notices about a lapse in government funding affecting website operations and the NIH Clinical Center, along with a software version update (Revision: v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedA glossary toggle was added, and new labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' appeared, while 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed.SummaryDifference0.2%

- Check35 days agoChange DetectedAn updated site revision label, Revision: v3.3.4, was added to the footer, replacing the previous Revision: v3.3.3. This change appears to be a UI/version string update and does not modify study content, eligibility criteria, or results.SummaryDifference0.0%

- Check64 days agoChange DetectedNew trial locations were added (Barcelona, Gran Canaria, La Coruña, Madrid, Pontevedra, Vizcaya) and existing location blocks were removed to reflect updated site availability for NADIM II.SummaryDifference0.6%

- Check86 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No changes to study content or page layout were observed.SummaryDifference0.0%

Stay in the know with updates to NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NADIMII: Immunotherapy in Pre-Surgical Breast Cancer Clinical Trial page.